Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Nozomu Uematsu"'
Publikováno v:
Nihon Naika Gakkai Zasshi. 111:977-983
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6df2dd9e3154c68f424656050e3f63f
https://doi.org/10.2169/naika.111.977
https://doi.org/10.2169/naika.111.977
Autor:
Hikaru Kobayashi, Yuki Hiroshima, Keijiro Sato, Masahiko Sumi, Toshimitsu Ueki, Hiroko Kazumoto, Nozomu Uematsu, Tsutomu Shishido, Mari Kitahara, Takehiko Kirihara
Publikováno v:
Internal Medicine
We present the case of a 53-year-old woman with prefibrotic stage primary myelofibrosis (PMF) who underwent cord blood transplantation. Nine years after transplantation, she relapsed, which was confirmed by a bone marrow examination. We decided to tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1b5325fbb36e2747233d9bffa86dad9
http://europepmc.org/articles/PMC7691036
http://europepmc.org/articles/PMC7691036
Autor:
Takehiko Kirihara, Hiroko Kazumoto, Kunihiko Shimizu, Masahiko Sumi, Mari Kitahara, Yuki Hiroshima, Hikaru Kobayashi, Keijiro Sato, Nozomu Uematsu, Toshimitsu Ueki, Tsutomu Shishido
Publikováno v:
Internal Medicine
A 51-year-old woman with Philadelphia chromosome-positive acute lymphoblastic leukemia underwent a second cord blood transplantation followed by maintenance therapy with interferon-α. After 33 months, she developed cardiogenic shock caused by advanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d144aba8330914323a9850f207463d1
https://doi.org/10.2169/internalmedicine.3322-19
https://doi.org/10.2169/internalmedicine.3322-19
Autor:
Hikaru Kobayashi, Hiroko Kazumoto, Masahiko Sumi, Hiroko Kaiume, Keijiro Sato, Toshimitsu Ueki, Yuki Hiroshima, Kazumi Norose, Masahide Watanabe, Nozomu Uematsu, Mari Kitahara, Tsutomu Shishido, Kenji Hikosaka
Publikováno v:
Transplant infectious disease : an official journal of the Transplantation SocietyREFERENCES. 23(6)
Background Toxoplasmosis is a rare but life-threatening infection occurring in immunocompromised hosts, including allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients. However, thus far, the clinical features and incidence of tox
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::982763da8867ec6a4422f52c070c080e
https://pubmed.ncbi.nlm.nih.gov/34542220
https://pubmed.ncbi.nlm.nih.gov/34542220
Autor:
Tsutomu, Shishido, Yuki, Hiroshima, Nozomu, Uematsu, Hiroko, Kazumoto, Hiroko, Kaiume, Takehiko, Kirihara, Wataru, Takeda, Toshimitsu, Ueki, Masahiko, Sumi, Hikaru, Kobayashi
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 59(6)
An 81-year-old woman presented to our hospital with anemia. Complete blood counts revealed macrocytic anemia; however, serum vitamin B12 and folate levels were normal. Bone marrow aspiration revealed multilineage dysplasia, and the patient was initia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8c09736d75f7a5a92c4bcf2a0986e524
https://pubmed.ncbi.nlm.nih.gov/29973442
https://pubmed.ncbi.nlm.nih.gov/29973442
Autor:
Masahiko, Sumi, Keijiro, Sato, Nozomu, Uematsu, Hiroko, Kawaguchi, Tsutomu, Shishido, Hiroko, Kaiume, Wataru, Takeda, Takehiko, Kirihara, Toshimitsu, Ueki, Yuki, Hiroshima, Mayumi, Ueno, Naoaki, Ichikawa, Nobuyuki, Urasawa, Hikaru, Kobayashi
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 59(2)
Vascular adverse events (VAEs) in chronic myeloid leukemia (CML) patients treated with nilotinib (NIL) has become a; however, studies on strategies to prevent VAEs remain limited. Therefore, the present study investigated VAEs in 19 CML patients trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::91d550fba04a26b128bd3945fc3d5a00
https://pubmed.ncbi.nlm.nih.gov/29515064
https://pubmed.ncbi.nlm.nih.gov/29515064
Autor:
Ichiro Ito, Kentaro Miura, Hikaru Kobayashi, Yuta Nakano, Nobutaka Kobayashi, Nozomu Uematsu, Toshimitsu Ueki
Publikováno v:
AME Case Reports. 3:48-48
Pulmonary mucormycosis is relatively rare and occurs in immunosuppressed patients, for example, individuals with hematologic malignancies such as leukemia. As pulmonary mucormycosis increases rapidly and is often fatal, appropriate treatment includin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2acccf64f3ade75cf192f1b94435548
https://doi.org/10.21037/acr.2019.11.02
https://doi.org/10.21037/acr.2019.11.02